Globally renowned, vertically integrated pharmaceutical player engaged in Research and Development (R&D), manufacturing, and marketing of high-quality chemical and biologic medicines across diverse therapeutic areas.

QA - Officer, Jr. Executive, Executive
Area of work : IPQA, QMS, Qualification
Qualification : B.Pharma, M.Pharma
Experience (In Years) : 2 to 5

Sai Life Sciences is one of India’s fastest growing Contract Research, Development & Manufacturing Organizations. As a pure-play, full-service CRO-CDMO, we work with over a 100 global innovator pharma and biotech companies to accelerate the discovery, development, and commercialisation of their NCE small molecule programmes. Over the past two decades, Sai Life Sciences has served a diverse set of programmes, consistently delivering value based on its quality and responsiveness. Today, it has over 2000 employees across its facilities in India, UK and USA.

Genpact Limited, a global leader in business process and technology management services, leverages the power of smarter processes, smarter analytics and smarter technology to help its clients drive intelligence across the enterprise. Genpacts Smart Enterprise Processes (SEP) framework, its unique science of process combined with deep domain expertise in multiple industry verticals, leads to superior business outcomes.

Post : Lead Associate - Regulatory Affairs-LIF007376

Pelltech Healthcare is a privately owned WHO-GMP certified pharmaceutical company in India, having a dedicated state-of-art manufacturing facility where we focus on the production of high-quality conventional & modified released pellets and finished formulations in capsules and tablets, Pellets. Using years of experience in the pharmaceutical industry, we direct all of our expertise and knowledge in formulation, development, and manufacturing of a diverse range of semi-finished and finished pharmaceutical products for emerging markets.

Regulatory submission for the treatment of anaemia of chronic kidney disease based on the ASCEND phase III clinical trial programme, consisting of five trials that all met their primary efficacy and safety endpoints in non-dialysis and dialysis patients.

US FDA regulatory submission acceptance is the third major regulatory milestone for daprodustat following the European Medicines Agency (EMA) regulatory submission acceptance and approval of Duvroq in Japan

Takeda announced that it has received manufacturing and marketing approval from the Japan Ministry of Health, Labour and Welfare (MHLW) for Nuvaxovid® Intramuscular Injection (Nuvaxovid), a novel recombinant protein-based COVID-19 vaccine, for primary and booster immunization in individuals aged 18 and older. Novavax licensed and transferred its manufacturing technologies to enable Takeda to develop and manufacture the vaccine at its facility in Hikari. Takeda will begin distribution of Nuvaxovid doses purchased by the Government of Japan as soon as possible.

Serum institute of India, SII, gets exemption for Pneumococcal Polysaccharide Conjugate Vaccine from price control by National Pharmaceutical Pricing Authority  for five years.

TANUVAS is an autonomous institution governed by its Board of Management which regulates the polices of the university in accordance with the provision of act and statues. The Planning Board and the Finance Committee of the university also support the University administration. While the Boards of Studies of Faculties and the Academic Council look after the academic pursuits of the University, the research policy of the university is watched over by the Research Council of the University.

The PGIMER owes its inception to the vision of late Sardar Partap Singh Kairon, the then Chief Minister of Punjab and the distinguished medical educationists of the then combined state of Punjab, supported by the first Prime Minister of India Pt. Jawahar Lal Nehru who considered the institutions of scientific knowledge as temples of learning and the places of pilgrimage.

Post : Editorial Assistant (One Post)

Institute of Life Sciences (ILS), Bhubaneswar is a leading national institute in India. It is a multidisciplinary institute engaged in advanced research in Infectious Disease Biology, Cancer Biology, Genetics & Autoimmune Diseases, and Plant & Microbial Biotechnology.

Post : Research Associate-I (01 position)

Maharashtra Public Service Commission is an Autonomous Body constituted and set up under Article 315 of the Constitution of India to discharge the duties and functions as assigned under Article 320 of the Constitution. The Commission accordingly recommends suitable candidates for the various posts under the Government and advises Government on various service matters like formulation of recruitment rules, on promotions, transfers, and disciplinary proceedings, etc.

IGIMS was established on 19th November 1983, as an autonomous organisation on the pattern of All India Institute of Medical Sciences, New Delhi. The objective was to provide super specialty medical facilities in Bihar. On 27th January 1983 Cabinet approved the completion of this massive project in 4 phases within a span of six (6) years. According to the decision of State Government, 130.20 Acres of land was transferred to IGIMS

Post : Field Investigator

National Agri-Food Biotechnology Institute (NABI), Mohali invites applications from the motivated students for admission to the PhD degree program in Biotechnology starting July 2022 session. NABI is a recognized centre of Regional Centre for Biotechnology (RCB), Faridabad to conduct PhD (Biotechnology).

PhD (Biotechnology) Program Admission 2022

SIRO Clinpharm is one of the leading Global Clinical Research Organizations (CROs), offering full scope services conducting clinical trials in the Pharmaceutical, Biotechnology and Medical Devices sectors in compliance with International Standards. We are headquartered in India having global presence in USA, Israel and in Europe at Germany, Czech Republic, Greece, Estonia, Romania, Spain and France.

Post : Medical Writing Professionals

After a journey of growth spanning 27 years as Cadila Healthcare Ltd. and the Zydus Group, we have evolved and transformed ourselves in response to the changing times. Our legacy of over 70 years in healthcare and being dedicated to life in all its dimensions is reaffirmed in our new mission, vision and purpose. Unifying ourselves under the Zydus name, Cadila Healthcare Ltd., is renamed as Zydus Life sciences Ltd.

After a journey of growth spanning 27 years as Cadila Healthcare Ltd. and the Zydus Group, we have evolved and transformed ourselves in response to the changing times. Our legacy of over 70 years in healthcare and being dedicated to life in all its dimensions is reaffirmed in our new mission, vision and purpose. Unifying ourselves under the Zydus name, Cadila Healthcare Ltd., is renamed as Zydus Life sciences Ltd.

Torrent Pharma, the flagship Company of Torrent Group, with a turnover of Rs. 8005 Cr is one of the leading Pharma companies in the Country. We are the pioneers in initiating the concept of niche marketing in India and today is ranked amongst the leaders in therapeutic segment of cardiovascular (CV), central nervous system (CNS), gastro-intestinal (GI) and women healthcare (WHC). The Company also has significant presence in diabetology, pain management, gynaecology, oncology and anti-infective segments.

Nectar Lifesciences Ltd. is a fast growing Rs.3000 Crores Turnover Company engaged in manufacturing and marketing of API (Oral & Sterile), Formulations and Phytochemicals, having Global positions in API’s & Menthol. The Company is poised to make rapid strides in all areas of its business activities.

Teva is a global pharmaceutical leader and the worlds largest generic medicines producer, committed to improving health and increasing access to quality health solutions worldwide. Our employees are at the core of our success, with colleagues in over 80 countries delivering the world's largest medicine cabinet to 200 million people every day.